🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSELECT trial 4-year follow-up data released — sustained MACE reduction Page 2

SELECT trial 4-year follow-up data released — sustained MACE reduction

Dr.CardioMD Mon, Jun 8, 2026 at 11:48 AM 16 replies 240 viewsPage 2 of 4
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Jun 8, 2026 at 2:38 PM#6

Subscribing to this thread. SELECT trial 4-year data is exactly what I've been researching. 🙏

Last edited: Jun 8, 2026 at 7:38 PM
31 3lucas_SP_BR, lisa_labSD, adam_van and 28 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jun 8, 2026 at 2:55 PM#7

As a pharmacist, I want to add some clinical context to this discussion on SELECT trial 4-year data released .

Building on what DataDave said — the evidence base here is robust. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
6 10PharmD_Rodriguez, julia.endo, JessicaM_2024 and 3 others
Reply Quote Save Share Report
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Jun 8, 2026 at 3:12 PM#8

Reading this thread on SELECT trial 4-year data hits close to home. Dad of 2 checking in — I started at 261 lbs and felt like I would tried everything.

7 months on tirz and I am a different person. Not just the 36 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about SELECT trial 4-year — take the leap. It was the best health decision I have ever made. ❤️

43 22pam_columbus, nick_SD_fit, ben_calgary and 40 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jun 8, 2026 at 3:29 PM#9

andrew_nyc — that is really helpful context on SELECT trial 4-year data. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

31 8PharmHunterJen, TomTeleRx, DoseLogDan and 28 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jun 8, 2026 at 3:46 PM#10

To answer wanda_boise's question specifically:

From a clinical standpoint, SELECT trial 4-year data is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

43 11carl_compliance, DanielChem_CHI, marco_milano and 40 others
Reply Quote Save Share Report

Similar Threads

GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register